A nerve-computer interface (NCI) system that allows amputees and paralyzed patients to intuitively control devices like robotic limbs or computers, simply by thinking.
The First Free-Will Brain Machine Interface Technology
Fasikl’s revolutionary free-will neural-computer interface system, allows amputees and paralyzed patients to intuitively control devices like robotic limbs or computers, simply by thinking.
With this groundbreaking technology, patients can effortlessly demonstrate precise control over individual finger joints, allowing them to be able to do everyday tasks, and even engage in mind-controlled video gaming.
For their work, Fasikl has received two simultaneous breakthrough device designations from the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) for its implantable platform, one for mind control of devices, the other to treat pain by restoring sensations.
The Future is Here: Nerve-Computer Interface Technology
The futuristic brain-machine interface, often depicted in science fiction, is now on the cusp of becoming a reality. While the full range of applications for BCI technology may currently appear vast and uncertain, it is anticipated that patients suffering from movement disorders, paralysis, or limb loss will be among the first to benefit significantly from future advancements in BCI.
Fasikl is a pioneer in this exciting field. NCI Nerve-computer interface system is Fasikl’s unique approach to BCI brain-computer interface technology, creating advanced functioning for patients without the increased risks associated with interventions to the brain.
By bridging the gap between human cognition and computing systems, Fasikl has unlocked new possibilities for individuals with physical disabilities with applications of this technology spanning from medical rehabilitation and therapeutic interventions to gaming and education.
Fasikl’s mission is to propel progress in this field, pioneering treatments that make a profound difference in the wellbeing of patients.
Disclaimer: MindForce™ is currently not FDA approved or cleared. It will be studied in clinical trials to support a future marketing application to the FDA.